The Pathologist Perspective: Identifying Systemic Mastocytosis in the Community
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Is it Nonresponsive/Progressive ISM?
Accurate Diagnosis and Management of Hereditary Alpha Tryptasemia
HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management
Carey Anders, MD, FASCO
Sarah Sammons, MD
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
Heather McArthur, MD
Margaret Gatti-Mays, MD, MPH
Overcoming EGFR Resistance With HER3-Directed ADCs
Helena Yu, MD
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Pasi Antero Jänne, MD, PhD
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
HER3-Directed ADCs in the Treatment of EGFR-Mutated Advanced or Metastatic NSCLC Progressing on TKI and Platinum-Based Chemotherapy
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.